Carlson Capital L P Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Carlson Capital L P

  • $617 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$83.14 - $145.99 $42.4 Million - $74.5 Million
510,000 New
510,000 $74.3 Million
Q1 2019

May 14, 2019
SELL
$34.52 - $53.29 $472,785 - $729,859
-13,696 Closed
0 $0
Q4 2018

Feb 13, 2019
BUY
$29.75 - $42.9 $407,456 - $587,558
13,696 New
13,696 $506,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Carlson Capital L P Portfolio

Follow Carlson Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Carlson Capital L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email